Careers  |  Sign In  |  Register

Latest in Hematology-Oncology

Reuters Health • The Doctor's Channel Daily Newscast

Gemcitabine added to standard therapy improves survival in cervical cancer

NEW YORK (Reuters Health) – Patients with advanced cervical carcinoma have better progression-free survival when gemcitabine is added to concurrent cisplatin chemoradiotherapy and included in adjuvant therapy, an international team reports in the Journal of Clinical Oncology online March 28. Dr. Mauro...

Reuters Health • The Doctor's Channel Daily Newscast

Radiation for prostate cancer increases hip fracture risk

NEW YORK (Reuters Health) – Men who receive radiation treatment for prostate cancer are at greater risk of hip fracture, a new study in the March 16 issue of Cancer reports. Based on the findings, men with prostate cancer considering their treatment options should be told about the risk associated with...

Mutations and B-Raf protein

Cancer and Melanoma

David B. Solit, MD, Elizabeth and Felix Rohatyn Chair for Junior Faculty, Memorial Sloan-Kettering Cancer Center, discusses B-Raf, an intracellular signaling protein.B-Raf is commonly mutated in cancer, and about 8% of all human cancers have B-Raf mutation. This in turn makes the cells grow abnormally and...